New substance library to accelerate the search for active compounds

For the study, the enzyme endothiapepsin (grey) was combined with molecules from the fragment library. The analysis shows that numerous substances are able to dock to the enzyme (blue and orange molecules). Every substance found is a potential starting point for the development of larger molecules.

For the study, the enzyme endothiapepsin (grey) was combined with molecules from the fragment library. The analysis shows that numerous substances are able to dock to the enzyme (blue and orange molecules). Every substance found is a potential starting point for the development of larger molecules. © J. Wollenhaupt/HZB

The fragment libraries, which the MX team has assembled together with a group from the University of Marburg, are also available to users at BESSY II. The diagram shows the fragment-screening workflow.

The fragment libraries, which the MX team has assembled together with a group from the University of Marburg, are also available to users at BESSY II. The diagram shows the fragment-screening workflow. © HZB

In order to accelerate the systematic development of drugs, the MX team at the Helmholtz-Zentrum Berlin (HZB) and the Drug Design Group at the University of Marburg have established a new substance library. It consists of 1103 organic molecules that could be used as building blocks for new drugs. The MX team has now validated this library in collaboration with the FragMAX group at MAX IV. The substance library of the HZB is available for research worldwide and also plays a role in the search for substances active against SARS-CoV-2.

For drugs to be effective, they usually have to dock to proteins in the organism. Like a key in a lock, part of the drug molecule must fit into recesses or cavities of the target protein. For several years now, the team of the Macromolecular Crystallography Department (MX) at HZB headed by Dr. Manfred Weiss together with the Drug Design Group headed by Prof. Gerhard Klebe (University of Marburg) has therefore been working on building up what are known as fragment libraries. These consist of small organic molecules (fragments) with which the functionally important cavities on the surface of proteins can be probed and mapped. Protein crystals are saturated with the fragments and then analysed using powerful X-ray light. This allows three-dimensional structural information to be obtained at levels of atomic resolution. Among other things, it is possible to find out how well a specific molecule fragment docks to the target protein. The development of these substance libraries took place as part of the joint Frag4Lead research project and was funded by the German Federal Ministry of Education and Research (BMBF).

The MX team (MX stands for Macromolecular Crystallography) has now published the design of a chemically diverse fragment library called the “F2X-Universal“ library, which consists of 1,103 compounds. A representative selection of 96 compounds has been extracted from this library, which is referred to as the F2X Entry Screen. In the course of publishing the library, this selection has now been successfully tested and validated by the MX team of the HZB at the MAX IV X-ray source in Lund, Sweden and at BESSY II.

In the study, the HZB and MAX IV teams verified the efficiency of the F2X Entry library by screening endothiapepsin and the Aar2/RnaseH protein complex as the target enzymes. In the next step, the MX team will use the entire universal library.

“For the current study, the fragment screening experts at HZB - BESSY II worked very closely with the FragMAX project team at MAX IV“, said Dr. Uwe Müller from the MX team at HZB who helped to set up the three MX beamlines at BESSY II as well as the BioMAX beamline at MAX IV. “This enabled both partners to further develop their own technology platforms and use them for imaging the functional surfaces of different proteins. This will be an excellent basis for future collaboration between MAX IV and HZB.“

arö

  • Copy link

You might also be interested in

  • CIGS-perovskite tandem cell achieves record efficiency of 25.5 %
    News
    30.06.2026
    CIGS-perovskite tandem cell achieves record efficiency of 25.5 %
    A Berlin-based team from HZB and Center for the Science of Materials Berlin (CSMB) at the Humboldt-Universität zu Berlin has set a new record for a tandem solar cell. Using a combination of a CIGS semiconductor layer and perovskite, along with several optimised intermediate layers, they were able to convert 25.5% of sunlight into electrical energy. The previous record for this combination of materials and this size of cell stood at 24.6%. The new record has been certified and is visible in the prestigious Solar Cell Efficiency Tables (the "Green Tables"), which serve as the definitive ledger for the global photovoltaic community.
  • Disorder creates new properties in compound semiconductors
    Science Highlight
    29.06.2026
    Disorder creates new properties in compound semiconductors
    An international research team has demonstrated that the intrinsic disorder of the compound semiconductor CuInSnS₄ can be exploited to influence its optical properties. While the atomic vibrations also sense the local disorder, their response is averaged over many different local environments and therefore appear isotropic, as expected for a cubic crystal. In contrast, the optical excitations, known as excitons, are much more sensitive to the local arrangement of atoms. Surprisingly, they show a direction-dependent optical response even though the average crystal structure is cubic. These findings shed new light on the relationship between disorder and material properties, opening up new options for targeted 'disorder engineering' in optoelectronic and photocatalytic devices.
  • Perovskite solar cells: Predictions of long-term stability
    Science Highlight
    25.06.2026
    Perovskite solar cells: Predictions of long-term stability
    Reliable statements about the long-term stability of perovskite solar cells are still difficult to make. However, a new study by Dr Carolin Ulbrich’s team, published in the renowned journal Joule, highlights which methods are useful for this purpose and identifies areas where further research is needed.